AbbVie and Roche’s cancer drug snags another ‘breakthrough’ tag

Damian Garde

and Roche's venetoclax, awaiting FDA approval, picked up breakthrough therapy nod from the agency for its potential as part of a combination treatment for leukemia.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS